A 49-year-old male presented with continuous recurrent chronic gluteal pyoderma. A total surgical excision of a subcutaneous abscess, followed by skin graft surgery, was performed. Three days postsurgery, skin engraftment failure was observed with local infection signs, including pain and suppuration at the surgical wound site. Subsequent microbiological culture revealed the presence of multiple-organism infections, including extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae, New Delhi metallo-beta (␤)-lactamase 1 (NDM-1)-and ESBL-producing Escherichia coli, NDM-1-and ESBL-producing Citrobacter freundii, Proteus vulgaris, and methicillin-resistant Staphylococcus aureus (MRSA). We analyzed whole-genome sequences of E. coli and C. freundii by next-generation sequencing (NGS) using MiSeq (Illumina), which showed the presence of blaNDM-1 and blaCTX-M-55 in both strains and of blaCMY-48 only in C. freundii.
COL, colistin; CTX, cefotaxime; ESBL, extended-spectrum beta-lactamase; IPM-CS, imipenem-cilastatin; LVFX, levofloxacin; MEPM, meropenem; NDM-1, New Delhi metallo-beta-lactamase; TCG, tigecycline. In the Etest synergy test, breakpoint matching at each Etest strip replacement was as follows: LVFX (1 g/ml), IPM-CS (1 g/ml), COL (2 g/ml), TGC (1 g/ml), and RFP (4 g/ml). b MIC of COL after preparation of other agents by the Etest. c MIC of TGC after preparation of other agents by the Etest.
TGC-based regimens might be an option for combination therapy based on the in vitro results of this case. NDM-1-producing organisms and MRSA polymicrobial infection limited the selection of antimicrobial regimens in this case. The findings of the present case report might demonstrate the effectiveness of the combination of COL with RFP and a carbapenem, as this combination has previously shown activity in vitro (8) . A prospective controlled study is required to examine this further.
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